Mutations in RAS or BRAF did not affect OS, however, we did find that the few patients with RAS/BRAF wild-type cancers showed a worse RFS (P = 0.006) and a significantly increased tumor load (PCI score, P = 0.031) (Supplementary Fig. 2k, l). The gene discussed is BRAF; the disease is neoplasm.